207 - Challenging Cases in Transplant ID

Saturday, October 19, 2024

10:30 AM – 11:45 AM US PT

Location: Ballroom (West Hall B)

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Interactive Moderator(s)

Maricar Malinis, MD (she/her/hers)

Associate Professor of Medicine
Section of Infectious Diseases
Vanderbilt University Medical Center, TN, United States

Slides
Jennifer Cuellar-Rodriguez, MD, FIDSA

Staff Clinician
National Institute of Allergy and infectious Diseases
Bethesda, MD, United States

Panelist(s)

Steven Pergam, MD, MPH

Professor
Fred Hutchinson Cancer Center; University of Washington
Seattle, WA, United States
Aruna Subramanian, MD (she/her/hers)

Clinical Professor
Stanford University
Palo Alto, CA, United States
Veronica Dioverti, MD (she/her/hers)

Assistant Professor
Johns Hopkins
Baltimore, MD, United States
Rebecca Pellett Madan, MD, MS (she/her/hers)

Associate Professor
NYU Grossman School of Medicine/Hassenfeld Children's Hospital at NYU Langone
Brooklyn, NY, United States

Disclosure(s):

Maricar F. Malinis, MD: Moderna ( concluded): Advisor/Consultant; Paratek Pharmaceuticals, Inc.: Honoraria

Jennifer Cuellar-Rodriguez, MD, FIDSA: No financial relationships to disclose

Steven A. Pergam, MD, MPH: Cidara Therapeutics Inc.: Participate in company sponsored clinical trial (Ongoing); F2G Pharmaceuticals: Participate in company sponsored clinical trial (Ongoing); Global Life Technologies, Inc.: Grant/Research Support (Ongoing); SymBio Pharmaceuticals: Participate in company sponsored clinical trial (Ongoing)

Aruna Subramanian, MD: Moderna, Inc.: Grant/Research Support (Ongoing)

Veronica Dioverti, MD: No financial relationships to disclose

Rebecca Pellett Madan, MD, MS: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

analyze difficult cases involving immunocompromised hosts methodically;
diagnose difficult transplant id cases by utilizing standard and advanced diagnostic tests.